San Francisco Bay Area biotech stories.
Monday, August 6, 2012
Nile Therapeutics names drug-development veteran as CEO
Nile Therapeutics Inc. named Dr.
, a founder of Itero Biopharmaceuticals, as president and CEO
. Horton, who initially was appointed Nile's chief medical officer in June, replaces
, who served as part-time president and CEO of San Mateo-based Nile (OTC: NLTX) and whose Two River Group Holdings invested in Nile.
The company is developing cenderitide
, a treatment for acutely decompensated heart failure patients after they leave the hospital.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)